Cole Douglas G.
SEC CIK 1486373 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DNLI | Denali Therapeutics Inc. | Dir | 26.6K | — | — | 2 | 2022-06-02 | 2023-06-01 |
Most active insiders at DNLI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Watts Ryan J. | Pres, CEO, Dir | — | $580.8K |
| 2 | Schuth Alexander O. | COFO, Sec | — | $420.6K |
| 3 | Thornberry Nancy | Dir | — | $261.9K |
| 4 | Chin Peter Scott | Chief Medical Off | — | $36.9K |
| 5 | Van Hauwermeiren Timothy | Dir | — | — |
| 6 | Cook Jennifer E. | Dir | — | — |
| 7 | Krognes Steve E. | Dir | — | — |
| 8 | Schenkein David P | Dir | — | — |
| 9 | Klein Peter S | Dir | — | — |
| 10 | BAKER BROS. ADVISORS LP | Dir | — | — |
Cole Douglas G. made no open-market trades at DNLI in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-05 | 2023-06-01 | DNLI | Denali Therapeutics Inc. | Cole Douglas G. | Dir | A - Grant | $0.00 | +4,216 | 26.6K | +19% | $0 |
| D | 2022-06-06 | 2022-06-02 | DNLI | Denali Therapeutics Inc. | Cole Douglas G. | Dir | A - Grant | $0.00 | +5,986 | 22.3K | +37% | $0 |
Purchase Sale Sale after option exercise All abbreviations